Smile-Link Healthcare Global Berhad Past Earnings Performance
Past criteria checks 0/6
Smile-Link Healthcare Global Berhad's earnings have been declining at an average annual rate of -51.5%, while the Healthcare industry saw earnings growing at 22.4% annually. Revenues have been growing at an average rate of 5.1% per year.
Key information
-51.5%
Earnings growth rate
-52.7%
EPS growth rate
Healthcare Industry Growth | 31.5% |
Revenue growth rate | 5.1% |
Return on equity | -9.1% |
Net Margin | -8.3% |
Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Smile-Link Healthcare Global Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 33 | -3 | 18 | 0 |
31 Dec 23 | 35 | 0 | 17 | 0 |
30 Sep 23 | 35 | 0 | 17 | 0 |
30 Jun 23 | 36 | 1 | 17 | 0 |
31 Mar 23 | 35 | 1 | 17 | 0 |
31 Dec 22 | 35 | 1 | 17 | 0 |
30 Sep 22 | 33 | 0 | 20 | 0 |
30 Jun 22 | 32 | 0 | 23 | 0 |
31 Mar 22 | 32 | -1 | 22 | 0 |
31 Dec 21 | 31 | -2 | 21 | 0 |
30 Sep 21 | 31 | -1 | 16 | 0 |
30 Jun 21 | 31 | 0 | 12 | 0 |
31 Mar 21 | 28 | 1 | 12 | 0 |
31 Dec 20 | 26 | 1 | 11 | 0 |
30 Sep 20 | 26 | 1 | 10 | 0 |
30 Jun 20 | 26 | 1 | 10 | 0 |
31 Mar 20 | 28 | 2 | 10 | 0 |
31 Dec 19 | 29 | 2 | 11 | 0 |
31 Dec 18 | 11 | 2 | 3 | 0 |
31 Dec 17 | 25 | 4 | 5 | 0 |
31 Dec 16 | 18 | 3 | 4 | 0 |
Quality Earnings: SMILE is currently unprofitable.
Growing Profit Margin: SMILE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SMILE is unprofitable, and losses have increased over the past 5 years at a rate of 51.5% per year.
Accelerating Growth: Unable to compare SMILE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SMILE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (4.9%).
Return on Equity
High ROE: SMILE has a negative Return on Equity (-9.12%), as it is currently unprofitable.